Doseology Sciences Inc. (MOOD.CN)
CAD 0.15
(0.0%)
CAD 0.15
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CAD | -100.0% |
| 2022 | 7588.00 CAD | -98.84% |
| 2021 | 652.63 Thousand CAD | -0.97% |
| 2020 | 659.01 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q4 | - CAD | 0.0% |
| 2023 Q1 | - CAD | -100.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2022 Q1 | 446.23 Thousand CAD | -31.63% |
| 2022 Q4 | 7588.00 CAD | -98.13% |
| 2022 Q3 | 406.65 Thousand CAD | -4.71% |
| 2022 Q2 | 426.74 Thousand CAD | -4.37% |
| 2022 FY | 7588.00 CAD | -98.84% |
| 2021 Q2 | 727.97 Thousand CAD | 12.8% |
| 2021 FY | 652.63 Thousand CAD | -0.97% |
| 2021 Q4 | 652.63 Thousand CAD | -3.6% |
| 2021 Q3 | 676.99 Thousand CAD | -7.0% |
| 2021 Q1 | 645.37 Thousand CAD | -2.07% |
| 2020 Q4 | 659.01 Thousand CAD | 0.0% |
| 2020 FY | 659.01 Thousand CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | NaN% |
| Asep Medical Holdings Inc | - CAD | NaN% |
| BetterLife Pharma Inc. | 245.23 Thousand CAD | 100.0% |
| BioVaxys Technology Corp. | - CAD | NaN% |
| ChitogenX Inc. | 3.27 Million CAD | 100.0% |
| Rapid Dose Therapeutics Corp. | 2.12 Million CAD | 100.0% |
| Defence Therapeutics Inc. | 7871.00 CAD | 100.0% |
| Entheon Biomedical Corp. | - CAD | NaN% |
| Gemina Laboratories Ltd. | 205.98 Thousand CAD | 100.0% |
| Glow Lifetech Corp. | - CAD | NaN% |
| Lexston Life Sciences Corp. | - CAD | NaN% |
| Pharmala Biotech Holdings Inc. | - CAD | NaN% |
| MYND Life Sciences Inc. | - CAD | NaN% |
| Nova Mentis Life Science Corp. | - CAD | NaN% |
| PharmaTher Holdings Ltd. | - CAD | NaN% |
| PreveCeutical Medical Inc. | - CAD | NaN% |
| Telescope Innovations Corp. | - CAD | NaN% |